Add BrightSurf on Google Email

Science News for April 11, 2002


Nicorandil could improve outcome for angina patients

A randomized trial found that nicorandil reduced the risk of cardiovascular events in patients with stable angina, including deaths due to coronary heart disease and non-fatal heart attacks. The study showed a significant reduction in acute coronary syndromes and all cardiovascular events compared to the placebo group.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 11, 2002

Support for colorectal cancer screening

A UK trial suggests that flexible sigmoidoscopy is a suitable tool for population screening of colorectal cancer, with high attendance rates and low perforation risks compared to colonoscopy. The study's findings highlight the need for tailored approaches to screening, taking into account individual risk factors and efficiency.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 11, 2002

Improving golf scores

A Northeastern University study reveals a significant decline in average scores of top golfers at the Masters Tournament from the 1930s to 2001, indicating rapid improvement and increased competition. The study also found that Tiger Woods' level of dominance is comparable to Jack Nicklaus' record-breaking performance in 1965.

SourceNortheastern University·JournalJournal of Applied Statistics·DateApr 11, 2002

Earth's warming trend is truly global

A team of researchers has found that the continents have warmed significantly over the past half-century, similar to the warming of the oceans, atmosphere, and ice. The study used temperature readings from six continents to reconstruct a temperature history for the Earth's surface over the past 500 years.

SourceUniversity of Michigan·JournalGeophysical Research Letters·DateApr 11, 2002

Early promise for dementia drug

A new study found that galantamine improves cognition and daily living activities in patients with vascular dementia. The medication was also shown to reduce symptoms of behavioural changes, providing a potential treatment option for patients with limited pharmacological help.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 11, 2002